甲状腺功能异常新型冠状病毒感染临床应对指南
Guidelines for clinical management of abnormal thyroid function in patients with novel coronavirus infection
中华医学会内分泌学分会 . 甲状腺功能异常新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023 , 18(01) : 13 -15 . DOI: 10.16138/j.1673-6087.2023.01.004
| [1] | McDermott MT. Hyperthyroidism[J]. Ann Intern Med, 2020, 172(7): ITC49-ITC64. |
| [2] | Chaker L, Razvi S, Bensenor IM, et al. Hypothyroidism[J]. Nat Rev Dis Primers, 2022, 8(1): 30. |
| [3] | Scappaticcio L, Pitoia F, Esposito K, et al. Impact of COVID-19 on the thyroid gland: an update[J]. Rev Endocr Metab Disord, 2021, 22(4): 803-815. |
| [4] | Poma AM, Basolo A, Bonuccelli D, et al. Activation of type Ⅰ and type Ⅱ interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19[J]. Thyroid, 2021, 31(12): 1766-1775. |
| [5] | Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism[J]. Eur J Endocrinol, 2020, 183(1): G33-G39. |
| [6] | 中华医学会内分泌学分会, 中国医师协会内分泌代谢科医师分会, 中华医学会核医学分会, 等. 中国甲状腺功能亢进症和其它原因所致甲状腺毒症诊治指南[J]. 中华内分泌代谢杂志, 2022, 38(8): 700-748. |
| [7] | Burch HB, Cooper DS. Anniversary review: antithyroid drug therapy 70 years later[J]. Eur J Endocrinol, 2018, 179(5): R261-R74. |
| [8] | 中华医学会呼吸病学分会危重症学组, 中国医师协会呼吸医师分会危重症医学专家组. 奥密克戎变异株所致重症新型冠状病毒感染临床救治专家推荐意见[EB/J]. 中华结核和呼吸杂志, 2023. https://rs.yiigle.com/yufabiao/1442297.htm. |
| [9] | Wartofsky L. Myxedema coma[J]. Endocrinol Metab Clin North Am, 2006, 35(4):687-698. |
| [10] | Pearce EN, Farwell AP, Braverman LE. Thyroiditis[J]. N Engl J Med, 2003, 348(26): 2646-2655. |
| [11] | Ahn HY, Choi HS, Ha S, et al. Incidence of subacute thyroiditis during the COVID-19 pandemic in South Korea using the National Health Insurance Service Database[J]. Thyroid, 2022, 32(11): 1299-1306. |
| [12] | Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis[J]. Lancet Diabetes Endocrinol, 2020, 8(9): 739-741. |
/
| 〈 |
|
〉 |
